75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Nature of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - License and Collaboration Agreement link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Convertible Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Respective Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurements within the Fair Value Hierarchy of Financial Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Investments - Schedule of Investments (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Investments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Property and Equipment, Net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - License and Collaboration Agreement - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Convertible Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Convertible Preferred Stock - Summary of Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Common Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Stock-Based Compensation - Summary of Stock Option Award Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Stock-Based Compensation - Schedule of Ranges of Assumptions Used in Black-Scholes Option-Pricing Model (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Award Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Segments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Segments - Schedule of Significant Segment Expenses Regularly Provided to the CODM (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Segments - Schedule of Significant Segment Expenses Regularly Provided to the CODM (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Net Loss per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Related Parties - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted-Average Fair Value, Vested Accrued Research And Development Expense Current Accrued research and development expense current. Accrued research and development expense Entity Incorporation, State or Country Code Plan Name [Axis] Research and Development Expense [Abstract] Research and development expenses: Securities in unrealized loss position for more than twelve months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Equity [Abstract] Entity Current Reporting Status JAPAN Operating expenses: Fair Value, Inputs, Level 2 [Member] Significant Other Observable Inputs (Level 2) Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common stock, shares authorized Common Stock, Shares Authorized Temporary Equity, Par or Stated Value Per Share Convertible preferred stock, par value Investment, Policy [Policy Text Block] Investments Product and Service [Axis] Document Fiscal Period Focus Entity Shell Company First Patient Dosed in First Phase 3 Clinical Trial [Member] First patient dosed in the first phase 3 clinical trial First Patient Dosed in First Phase 3 Clinical Trial Temporary Equity, Shares Outstanding Preferred Stock Outstanding Convertible preferred stock, outstanding Ending balance, shares Beginning balance, shares Other Accrued Liabilities, Current Accrued other Segment Reporting, Policy [Policy Text Block] Segment Information Cash and cash equivalents Cash and Cash Equivalent Cash and Cash Equivalent, Total Government Grants [Policy Text Block] Government grants. Government Grants Common Stock, Shares, Issued Common stock, shares issued Series A One Preferred Stock As Converted to Common Stock [Member] Series A one preferred stock as converted to common stock. Series A-1 Preferred Stock (as Converted to Common Stock) Statement [Table] Operating lease right-of-use assets obtained in exchange for lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Increase to operating lease right of use asset and lease liability Share-Based Payment Arrangement, Disclosure [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant date fair value of options granted Board of Directors and Chief Executive Officer [Member] Board of Directors and Chief Executive Officer. Board of Directors and Chief Executive Officer Statement [Line Items] Entity Filer Category Debt Securities Available For Sale Unrealized Gain Position Debt securities available for sale unrealized gain position. Net unrealized gain position Selling, General and Administrative Expenses, Policy [Policy Text Block] General and Administrative Expenses Liabilities and Equity Total liabilities, convertible preferred stock and stockholders' deficit Payables and Accruals [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, Exercisable Long-Lived Tangible Asset [Axis] Scenario Three [Member] Scenario three. Scenario Three Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total Foreign currency translation adjustment Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Subsequent Event [Line Items] Effective Income Tax Rate Reconciliation, Percent Effective tax rates Stock Option Activity Geographical [Domain] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents, and Restricted Cash Organization, Consolidation and Presentation of Financial Statements [Table] Organization, consolidation and presentation of financial statements. Grant agreement, maximum total funding amount Grant Agreement Maximum Funding Amount Grant agreement maximum funding amount. Additional Paid in Capital, Common Stock Additional paid-in capital Related Party Related Party [Member] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Property, Plant and Equipment [Line Items] Summary of Cash, Cash Equivalents, and Restricted Cash Schedule of Cash and Cash Equivalents [Table Text Block] Vesting [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of Stock Options, Granted Number of stock options granted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Basic and Diluted Net Loss Per Share Earnings Per Share, Basic Net loss per share, basic Earnings Per Share, Basic, Total Service-Based Vesting Service-Based Vesting [Member] Service-based vesting. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Cumulative translation adjustment Number of Stock Options, Outstanding, Beginning Balance Number of Stock Options, Outstanding, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of options Interest Income (Expense), Nonoperating Interest Income (Expense), Nonoperating, Total Interest income, net Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Personnel Related [Member] Personnel related. Personnel-related Equity, Attributable to Parent [Abstract] Stockholders' deficit Health Care Organization, Revenue Sources [Domain] Entity Small Business Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated deficit Two Thousand and Twenty Four Equity Incentive Plan [Member] Two thousand and twenty four equity incentive plan. 2024 Equity Incentive Plan Share Based Compensation Arrangement By Share Based Payment Award, Unvested Amount, Percentage Share based compensation arrangement by share based payment award, unvested amount, percentage. Unvested amounts, percentage Preferred Stock [Member] Preferred Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of Stock Options, Forfeited Number of Stock Options, Forfeited Share price per share Sale of Stock, Price Per Share Public offering price Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Organization, Consolidation and Presentation of Financial Statements [Abstract] Payment of Deferred Offering Costs Payment of deferred offering costs. Payment of deferred offering costs Leases [Abstract] Amendment Flag Product and Service [Domain] Loss Contingencies [Line Items] Award Agreement First Phase of Research Committed Funding Amount Award agreement first phase of research committed funding amount. Award agreement, first phase of research committed funding amount Earnings Per Share, Policy [Policy Text Block] Net Loss per Share Liabilities and Equity [Abstract] Liabilities, convertible preferred stock and stockholders' deficit Entity Address, Postal Zip Code Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Net cash used in operating activities Operating lease liability Increase (Decrease) in Operating Lease Liability Voting [Member] Voting. Voting Common Stock Common Stock Common Stock [Member] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Granted Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less: Accumulated depreciation Debt Securities, Available-for-Sale [Line Items] Entity Address, Address Line One Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Ranges of Assumptions Used in Black-Scholes Option-Pricing Model Fair Value Hierarchy and NAV [Axis] Milestones payment earned Milestones payment earned. Milestones Payment Earned Earnings Per Share [Abstract] Income Tax, Policy [Policy Text Block] Income Taxes Temporary Equity, Carrying Amount, Attributable to Parent Carrying Value Convertible preferred stock Beginning balance Ending balance Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Net Proceeds After Deducting Underwriter Discounts Commissions And Other Offering Expenses Net proceeds after deducting underwriter discounts commissions and other offering expenses. Net proceeds after deducting underwriter discounts, commissions and other estimated offering expenses Operating Lease, Right-of-Use Asset Right-of-use assets - operating leases Debt Securities, Available-for-Sale, Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Total Net unrealized loss position OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total Unrealized gain (loss) on investments Unrealized (loss) gain on available-for-sale securities Changes in operating assets and liabilities: Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Document Type Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Lab Equipment [Member] Lab equipment. Lab Equipment Entity Central Index Key Common Stock Text Block Common stock text block. Common Stock Debt Securities, Available-for-Sale [Table Text Block] Schedule of Investments Maximum Amount Of Successful development Milestones per Licensed Product Maximum amount of successful development milestones per licensed product. Maximum amount of successful development milestones per licensed product License and Collaboration Agreement [Table] License and collaboration agreement. Investments, Debt and Equity Securities [Abstract] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net increase (decrease) in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Subsequent Event Type [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities excluded from calculation of diluted net loss per share attributable to common stockholders Common Stock, Par or Stated Value Per Share Common stock, par value Award Agreement Maximum Funding Amount Award agreement maximum funding amount. Award agreement, maximum total funding amount Security Deposit Security deposit Share-Based Payment Arrangement, Tranche One [Member] Unvested Amount Subject to Accelerated Vesting Upon Close of Series B Financing Service-Based Vesting Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of operating lease right-of-use assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Term (in years), Outstanding Weighted-Average Remaining Contractual Term (in years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Volatility, maximum Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of Stock Options, Exercised Other Prepaid Expense, Current Prepaid other Investment [Text Block] Investments Supplemental disclosure of non-cash operating, financing, and investing information: Supplemental disclosure of non-cash operating, financing, and investing information: Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Document Quarterly Report PureTech Under TSA PureTech Under TSA [Member] PureTech Under TSA Member. Entity Address, State or Province Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Units, Unvested, Beginning Balance Number of Units, Unvested, Ending Balance Unvested shares of restricted common stock Financial liabilities fair value Financial Liabilities Fair Value Disclosure Financial Liabilities Fair Value Disclosure, Total Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Holding Gains Net unrealized gain position Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Common Stock, Capital Shares Reserved for Future Issuance Common stock were initially reserved for issuance Common stock, initially reserved for issuance Geographical [Axis] Conversion of stock, shares converted Conversion of Stock, Shares Converted Other general and administrative expenses Other General and Administrative Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-Based Compensation Expense Related party payable Increase (Decrease) in Due to Related Parties, Current Increase (Decrease) in Due to Related Parties, Current, Total Stock options exercised Stock Issued During Period, Value, Stock Options Exercised Comprehensive Income, Policy [Policy Text Block] Comprehensive Loss Accrued Bonuses, Current Accrued personnel and bonus expense Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Asset Transfer Agreement [Member] Asset Transfer Agreement. Asset Transfer Agreement Interest and Other Income Other segment items Collaborative Arrangement Disclosure [Text Block] License and Collaboration Agreement Performance-Based Options Performance Shares [Member] Research and development tax credit Research and Development Tax Credit Research and development tax credit. Deferred Offering Costs Included In Accounts Payable And Accrued Expenses Deferred offering costs included in accounts payable and accrued expenses. Deferred offering costs included in accounts payable and accrued expenses Subsequent Event [Member] Subsequent Event Minimum preferred stock shares required for voting threshold Minimum Preferred Stock Shares Required for Voting Threshold Minimum preferred stock shares required for voting threshold. Property, Plant and Equipment [Abstract] Other Assets, Noncurrent Other non-current assets Schedule of Estimated Useful Lives of Property and Equipment [Table Text Block] Schedule of estimated useful lives of property and equipment. Schedule of Estimated Useful Lives Antidilutive Securities [Axis] Other Liability, Current, Related Party [Extensible Enumeration] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Total fair value of restricted stock awards, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value, Vested and expected to vest Related Party Transaction [Axis] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income Cash and Cash Equivalents [Domain] Prepaid Research And Development Prepaid research and development. Lessee, Operating Lease, Option to Extend Operating lease, option to extend Monash Collaboration Agreement and ARPA-H Grant Monash Collaboration Agreement and Advanced Research Projects Agency for Health Grant [Member] Monash Collaboration Agreement and Advanced Research Projects Agency for Health Grant. Minimum Minimum [Member] Financial Instrument [Axis] Assets, Current [Abstract] Current assets: Accounts Payable and Other Accrued Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities Fair Value, Inputs, Level 3 [Member] Significant Unobservable Inputs (Level 3) Segment Reporting [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Fair Value Measurements within the Fair Value Hierarchy of Financial Assets and Liabilities Accrued Professional And Legal Fees Accrued professional and legal fees. Accrued professional and legal fees Liabilities, Current [Abstract] Current liabilities: Maximum amount of successful commercial milestones per licensed product Maximum Amount Of Successful Commercial Milestones per Licensed Product Maximum amount of successful commercial milestones per licensed product. Related Party Transactions [Abstract] Asset Acquisitions And Acquired In-Process Research And Development Expenses [Policy Text Block] Asset acquisitions and acquired in-process research and development expenses. Asset Acquisitions and Acquired In-Process Research and Development Expenses Shares, Outstanding Ending balance, shares Beginning balance, shares Lessee, Operating Lease, Renewal Term Operating lease, renewal term Restricted cash within other non-current assets Restricted Cash and Cash Equivalent Restricted Cash and Cash Equivalent, Total Commitments and contingencies (Note 14) Commitments and Contingencies Leases Lessee, Leases [Policy Text Block] Weighted Average Fair Value, Unvested, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Fair Value, Unvested, Beginning Balance General and Administrative Expense [Member] General and administrative General and Administrative Expense Stockholders' Equity, Reverse Stock Split Reverse stock split Forecast [Member] Scenario Forecast Organization, consolidation and presentation of financial statement [Line Items] Organization, consolidation and presentation of financial statement. Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Effect of exchange rates on cash and cash equivalents Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Loss Contingencies [Table] Weighted Average Number of Shares Outstanding, Basic Weighted-average shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average common shares outstanding, basic Scenario [Axis] Cumulative Translation Adjustment Cumulative translation adjustment. Cumulative translation adjustment Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Long-Lived Tangible Asset [Domain] Australia research and development tax credit receivable Australia Research And Development Tax Credit Receivable Australia research and development tax credit receivable. Subsequent Events [Text Block] Subsequent Events Related Party Transactions Disclosure [Text Block] Related Parties APIC, Share-Based Payment Arrangement, Increase for Cost Recognition APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation expense Equity, Attributable to Parent Total stockholders' deficit Ending balance Beginning balance Payments to Acquire Investments Payments to Acquire Investments, Total Purchase of investments Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Grant agreement, uncommitted funding amount Grant Agreement Uncommitted Funding Amount Grant agreement uncommitted funding amount. Lessee, Operating Lease, Existence of Option to Extend [true false] Statement of Stockholders' Equity [Abstract] Share-Based Payment Arrangement, Tranche Two [Member] Unvested Amount Subject to Future Acceleration Upon Close of Initial Public Offering Performance Based Vesting Use of Estimates, Policy [Policy Text Block] Use of Estimates Number Of Annual Installments Vested Number of annual installments vested. Number of annual installments vested Over-Allotment Option [Member] Underwriters' Overallotment Option Leasehold Improvements [Member] Leasehold Improvements 2026 Employee stock purchase plan Employee Stock Purchase Plan [Member] Employee stock purchase plan. Fair Value Disclosures [Text Block] Fair Value Measurements Stock Option, Exercise Price, Increase Exercise price UNITED STATES Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Plan Name [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Entity [Domain] License And Collaboration Agreement [Line Items] License and collaboration agreement. Glyph2BLSD Direct Research and Development Expenses [Member] Glyph2BLSD direct research and development expenses. Glyph2BLSD Direct Research and Development Expenses Related and Nonrelated Parties [Axis] Percentage on Net Sales Percentage on net sales. Percentage on net sales Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Accounting Standards Update [Extensible Enumeration] Scenario Five [Member] Scenario five. Scenario Five Entity Address, City or Town Deferred Offering Costs Deferred Offering Costs [Policy Text Block] Deferred offering costs. Grant agreement, committed funding amount Grant Agreement Committed Funding Amount Grant agreement committed funding amount. Number of Reportable Segments Number of reportable segments Security Exchange Name Europe [Member] EUROPE Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment Deferred Offering Costs Deferred offering costs Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of Stock Options, Vested and expected to vest Antidilutive Securities, Name [Domain] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance Total cash, cash equivalents, and restricted cash per the condensed consolidated statements of cash flows Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement [Domain] Health Care Organization, Revenue Sources [Axis] Assets, Current Total current assets Share-Based Payment Arrangement, Expense Stock-based compensation expense Document Period End Date Title and Position [Axis] Fair Value Hierarchy and NAV [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Number of Stock Options, Exercisable Series A-2 Preferred Stock Purchase Agreement Series A-2 Preferred Stock Purchase Agreement [Member] Series A-2 Preferred Stock Purchase Agreement. Statement of Financial Position [Abstract] Prepaid Expenses And Other Current Assets Text Block The entire disclosure of prepaid expenses and other current assets. Prepaid Expenses and Other Current Assets Preclinical and Early Discovery Assets Preclinical and Early Discovery Assets [Member] Preclinical and early discovery assets. Stock Issued During Period, Shares, Purchase of Assets Issuance of common stock Shares issued as part of the consideration for the assets Antidilutive Security, Excluded EPS Calculation [Table] Vesting [Axis] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Class of Stock [Axis] Research And Development Tax Credit [Policy Text Block] Research and development tax credit. Australia Research and Development Tax Credit Monash Collaboration Agreement and Advanced Research Projects Agency for Health Award [Member] Monash Collaboration Agreement and Advanced Research Projects Agency for Health Award. Monash Collaboration Agreement and ARPA-H Award Liabilities Total liabilities PureTech LYT Inc. PureTech LYT Inc.[Member] PureTech LYT Inc. PureTech LYT Increase Decrease In Accrued Expenses and Other Current Liabilities Increase (decrease) in accrued expenses and other current liabilities. Accrued expenses and other current liabilities Financial Instruments [Domain] GlyphAgo Direct Research and Development Expenses [Member] GlyphAgo direct research and development expenses. GlyphAgo Direct Research and Development Expenses Share Based Compensation Arrangement By Share Based Payment Award Cliff Vesting Period Share based compensation arrangement by share based payment award cliff vesting period. Cliff vesting period Award Agreement Second Phase of Research Maximum Uncommitted Funding Amount Award agreement second phase of research maximum uncommitted funding amount. Award agreement second phase of research maximum uncommitted funding amount Scenario Four [Member] Scenario four. Scenario Four Restricted Cash and Cash Equivalent, Statement of Financial Position [Extensible Enumeration] Restricted Stock [Member] Restricted Stock Awards Restricted Common Stock Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted-average common shares outstanding, diluted Entity File Number Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock. Series B Convertible Preferred Stock Cover [Abstract] Volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Conversion Price Adjustment, Percentage of Required Stockholders of Outstanding Shares Conversion price adjustment, percentage of required stockholders of outstanding shares. Percentage of required stockholders' outstanding shares Prepaid Expense and Other Assets, Current Prepaid and other current assets Prepaid expenses and other current assets Prepaid expenses and other current assets Scenario [Domain] US Treasury Securities [Member] U.S. Treasuries Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares authorized for issuance Number of Operating Segments Number of operating segments Sale of Stock [Domain] Segment Reporting Disclosure [Text Block] Segments General and Administrative Expense General and administrative (including stock-based compensation expense of $1.7 million and $1.1 million for the three months ended March 31, 2026 and 2025, respectively) Total general and administrative expenses Total general and administrative expenses Non-Voting Common Stock Non Voting [Member] Non-Voting. Preferred Stock, Convertible, Conversion Price Conversion Price per Share Conversion price Liquidation Preference Temporary Equity, Liquidation Preference Convertible preferred stock, Liquidation preference Subsequent Event [Table] Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Proceeds from maturities of investments GlyphAllo Direct Research and Development Expenses [Member] GlyphAllo direct research and development expenses. GlyphAllo Direct Research and Development Expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Vested and expected to vest Property, Plant and Equipment, Useful Life Property, plant and equipment, estimated useful lifes New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements / Recently Issued Accounting Standards Updates Not Yet Adopted Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period for stock options issued under the plan Annual Net Sales Percentage Annual net sales percentage. Annual net sales percentage Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Depreciation Depreciation, Total Depreciation expense Lessee, Operating Lease, Term of Contract Operating lease, term of contract Long-Term Investments Long-Term Investments, Total Long-term investments Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Operating Lease, Liability, Current Operating lease liability Document Transition Report Share-Based Payment Arrangement, Additional Disclosure [Abstract] Short-Term Investments Short-Term Investments, Total Short-term investments Operating Expenses Total operating expenses Research and development expense Total research and development expenses Research and development (including stock-based compensation expense of $0.9 million and $0.5 million for three months ended March 31, 2026 and 2025, respectively) Total research and development expenses Lessee, Operating Leases [Text Block] Leases Convertible Preferred Stock [Member] Series A-1 Convertible Preferred Stock Statement of Cash Flows [Abstract] Number of vote Number Of Vote Number of vote. Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Award Activity Milestone payments Milestone Payments Milestone payments. Seaport Glyph Product [Member] Seaport Glyph Product. Seaport Glyph Product Equity [Text Block] Convertible Preferred Stock Earnings Per Share [Text Block] Net Loss Per Share Net loss Net loss Net loss Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding, Beginning balance Aggregate Intrinsic Value, Outstanding, Ending balance Stock Option Term Limit Stock option term limit. Stock option term limit Monash License Agreement [Member] Monash License Agreement. Monash License Agreement Preferred Stock, Convertible, Shares Issuable Common Stock Issuable Upon Conversion Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield License and Collaboration Agreement [Abstract] License and Collaboration Agreement. Assets [Abstract] Assets Other indirect research and development expenses Other Indirect Research and Development Expenses Other indirect research and development expenses. Amortization of Debt Issuance Costs and Discounts Amortization of Debt Issuance Costs and Discounts, Total Net amortization of premium and discounts on investments Document Fiscal Year Focus Investing activities Investing activities Accounts Payable, Current Accounts Payable, Current, Total Accounts payable Research and Development Expense [Member] Research and development Research and Development Expense Other non-current assets Increase (Decrease) in Other Noncurrent Assets Summary of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Convertible Preferred Stock [Policy Text Block] Convertible preferred stock. Convertible Preferred Stock Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Sale of Stock, Consideration Received on Transaction Gross aggregate proceeds Aggregate gross proceeds from financings Unvested Restricted Stock Awards [Member] Unvested Restricted Stock Awards. Unvested Restricted Stock Awards Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized stock-based compensation expense Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Total financial assets Sale of Stock [Axis] Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Summary of Restricted Stock Award Activity Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash provided (used in) investing activities Series A-2 Preferred Stock (as Converted to Common Stock) Series A Two Preferred Stock As Converted To Common Stock [Member] Series A two preferred stock as converted to common stock. Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Weighted Average Exercise Price, Forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Money Market Funds [Member] Money Market Funds Related and Nonrelated Parties [Domain] Income Tax Disclosure [Text Block] Income Taxes Temporary Equity, Shares Issued Preferred Stock Issued Convertible preferred stock, issued Investment Charges For Credit Related Impairments Investment charges for credit-related impairments. Investment charges for credit-related impairments Legal Entity [Axis] Property, Plant and Equipment [Table Text Block] Schedule of Estimated Useful Lives Schedule of Property and Equipment, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Outstanding, Beginning Balance Weighted Average Exercise Price, Outstanding, Ending Balance Exercise price Income Tax Disclosure [Abstract] Fair Value, Recurring and Nonrecurring [Table] Additional Paid-in Capital [Member] Additional Paid-In Capital Measurement Frequency [Domain] Statement of Income Location, Balance [Axis] Change in Accounting Principle, Accounting Standards Update, Adoption Date Trading Symbol Series A and Series B Preferred Stock [Member] Series A and series B preferred stock. Series A and Series B Preferred Stock Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Related Party Transaction [Table] Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Additional milestone payments Additional Milestone Payments Additional milestone payments. Subsequent Event Type [Axis] Financing activities Financing activities Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Fair Value, Recurring Fair Value, Recurring [Member] Entity Ex Transition Period Convertible Preferred Stock, Automatic Conversion, Public Offering Amount, Threshold Convertible preferred stock, automatic conversion, public offering amount, threshold. Minimum proceeds from future initial public offering issuance Agreement Termination Notice Period Agreement termination notice period. Agreement termination notice period Equity Components [Axis] Total other income, net Nonoperating Income (Expense) Equity Component [Domain] Prepaid expenses and other current assets Increase (Decrease) In Prepaid Expenses and Other Current Assets Increase (decrease) in prepaid expenses and other current assets. IPO [Member] IPO Common Stock, Voting Rights Common stock, voting rights Initial Term of Agreement Initial term of agreement. Initial term of agreement Maximum [Member] Maximum Summary of Preferred Stock Schedule of Stock by Class [Table Text Block] Statistical Measurement [Axis] Common Stock, Value, Issued Common stock, par value $0.0001; 159,070,000 shares authorized; 2,595,342 and 2,594,960 shares issued and outstanding as of March 31, 2026 and December 31, 2025 respectively Related party expense due from affiliates Related Party Tax Expense, Due from Affiliates, Current Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets Accrued Liabilities Accrued Liabilities, Total Accrued liabilities Stock Purchase Agreement [Member] Stock purchase agreement with new and existing investors Stock Purchase Agreement or Series B Financing U.S. Treasuries Long-term Investments US Treasuries Long Term Investments [Member] US treasuries long term investments. Preferred Stock, Shares Authorized Preferred stock, shares authorized Intellectual Property Matters Intellectual Property Matters [Policy Text Block] Intellectual property matters. Related Party Transaction [Line Items] Entity Registrant Name Unrealized Holding Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Net unrealized loss position Transfers or reclassifications between fair value measurement levels of assets Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net, Total Subsequent Events [Abstract] U.S. Treasuries Short-term Investments US Treasuries Short Term Investments [Member] US treasuries short term investments. Income Tax Expense (Benefit) Income tax provision Income Tax Expense (Benefit), Total Measurement Frequency [Axis] Dividend paid Common Stock, Dividends, Per Share, Cash Paid Share Based Payment Arrangement, Option, Exercise Price, Percentage Stock option exercise price, percentage Share based payment arrangement, option, exercise price, percentage. Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive income Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock awards, granted Total assets Assets Property, Plant and Equipment [Table] Weighted-Average Remaining Contractual Term (in years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Income Statement [Abstract] Series A-1 Convertible Preferred Stock [Member] Series A-1 Convertible Preferred Stock. Series A-1 Convertible Preferred Stock Series B Preferred Stock (as Converted to Common Stock) Series B Preferred Stock As Converted To Common Stock [Member] Series B preferred stock as converted to common stock. Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Sale of Stock, Number of Shares Issued in Transaction Shares issued and sold Shares issued and sold Stock Issued During Period, Shares, New Issues Preferred Stock Authorized Temporary Equity, Shares Authorized Convertible preferred stock, authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of Units, Vested Number of shares vested Number of Units, Vested Earnings Per Share, Diluted Net loss per share, diluted Earnings Per Share, Diluted, Total Schedule of Significant Segment Expenses Regularly Provided to the CODM Schedule of Segment Reporting Information, by Segment [Table Text Block] Increase (Decrease) in Accounts Payable, Trade Accounts payable Title and Position [Domain] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] City Area Code Two Thousand And Twenty Four Plan Restricted Stock Awards [Member] Two thousand and twenty four plan restricted stock awards. 2024 Plan Restricted Stock Awards Two Thousand And Twenty Six Equity Incentive Plan Member Two thousand and twenty six equity incentive plan. 2026 Equity incentive plan Scenario One [Member] Scenario one. Scenario One Series A-2 Convertible Preferred Stock [Member] Series A-2 Convertible Preferred Stock. Series A-2 Convertible Preferred Stock Segment Reporting Information [Line Items] Stock split ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Royalties payment percentage Royalties payment percentage. Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Property and equipment, net Property, Plant and Equipment, Net Property and equipment, net Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation, Total Cash, cash equivalents, and restricted cash, beginning of period Cash, cash equivalents, and restricted cash, end of period Loss from operations Operating Income (Loss) Retained Earnings [Member] Accumulated Deficit Cash and Cash Equivalents [Axis] Stock-based compensation expense Employee Benefits and Share-Based Compensation Other Nonoperating Expense Other expense, net Operating lease liability, net of current portion Operating Lease, Liability, Noncurrent Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash used in financing activities Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Percentage of Additional Equity Awards Granted Percentage of additional equity awards granted. Percentage of additional equity awards granted Investments Investments, Fair Value Disclosure Investments, Fair Value Disclosure, Total Nonoperating Income (Expense) [Abstract] Other income (expense), net Performance Based Vesting [Member] Performance based vesting. Performance Based Vesting Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Outstanding Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders Debt Securities, Available-for-Sale [Table] Entity Interactive Data Current Statement of Income Location, Balance [Domain] Operating activities Operating activities Furniture and Fixtures [Member] Furniture and Fixtures Common Stock, Dividends, Per Share, Declared Dividend declared Entity Tax Identification Number Investments Maturity Period Investments maturity period. Investments maturity period Public offering price Share Price Prepaid Interest Interest receivable Scenario two. Scenario Two [Member] Scenario Two Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of Business and Basis of Presentation Local Phone Number Related Party Transaction [Domain] Other Liabilities, Current Related party payable Accounting Policies [Abstract] Cash, cash equivalents and investments Investments and Cash Investments and Cash, Total Payment of Development Milestones Payment of development milestones Payment of development milestones. Net sales Revenue from Contract with Customer, Excluding Assessed Tax General and administrative expenses: General and Administrative Expense [Abstract] Class of Stock [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for future grants Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized stock-based compensation expense, remaining weighted average period Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments, Total Cash, cash equivalents and marketable securities Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Stock, Class of Stock [Table] Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Term (in years), Vested and expected to vest Accounting Standards Update 2025 10 [Member] Accounting Standards Update 2025 10.